Anthracycline versus nonanthracycline adjuvant therapy for early breast cancer: A systematic review and meta-analysis

PURPOSE: The clinical benefits provided by using anthracycline-contained regimens in patients with early breast cancer (EBC) remain uncertain. This meta-analysis used data from all relevant trials to compare treatment outcomes for patients with EBC receiving adjuvant chemotherapy with non–anthracycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Wu, Li, Zhian, Wang, Caiyun, Dai, Jiangfeng, Ruan, GuoDong, Tu, Chuanjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211907/
https://www.ncbi.nlm.nih.gov/pubmed/30335021
http://dx.doi.org/10.1097/MD.0000000000012908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211907/
https://www.ncbi.nlm.nih.gov/pubmed/30335021
http://dx.doi.org/10.1097/MD.0000000000012908

Ejemplares similares